Sara Lundqvist

R&D BioPharmaceuticals, AstraZeneca
Moelndal, O 43183, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Spirocyclopentane as a Novel Scaffold for Potent Ghrelin Receptor Full Agonists.

Spirocyclopentane as a Novel Scaffold for Potent Ghrelin Receptor Full Agonists.

Journal: Journal of medicinal chemistry

Published: December 05, 2025

Exploring central sensitization symptoms in children with ADHD and their parents: a case-control study.

Exploring central sensitization symptoms in children with ADHD and their parents: a case-control study.

Journal: BMC psychiatry

Published: July 22, 2025

Generation of a potent & selective series of IRAK4 inhibitors based on a structure based, hybridization approach.

Generation of a potent & selective series of IRAK4 inhibitors based on a structure based, hybridization approach.

Journal: Bioorganic & medicinal chemistry

Published: June 11, 2025

Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist.

Preclinical evaluation and first-in-human phase 1 trial of AZD0186, a novel, oral small molecule glucagon-like peptide-1 receptor agonist.

Journal: The Journal of pharmacology and experimental therapeutics

Published: April 10, 2025

Somatic comorbidities and health related uncertainty among Swedish adolescents with ADHD.

Somatic comorbidities and health related uncertainty among Swedish adolescents with ADHD.

Journal: Frontiers in psychiatry

Published: November 25, 2024

Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.

Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.

Journal: Diabetes, obesity & metabolism

Published: September 20, 2024

Prevalence of chronic pain in children and adolescents with psychiatric conditions.

Prevalence of chronic pain in children and adolescents with psychiatric conditions.

Journal: Paediatric & neonatal pain

Published: March 22, 2022

Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoring.

Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoring.

Journal: PloS one

Published: January 17, 2022

The associations between ADHD, pain, inflammation, and quality of life in children and adolescents-a clinical study protocol.

The associations between ADHD, pain, inflammation, and quality of life in children and adolescents-a clinical study protocol.

Journal: PloS one

Published: August 26, 2021

Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists.

Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists.

Journal: Journal of medicinal chemistry

Published: August 14, 2020

In Situ Target Engagement Studies in Adherent Cells.

In Situ Target Engagement Studies in Adherent Cells.

Journal: ACS chemical biology

Published: February 13, 2018

Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.

Novel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.

Journal: PloS one

Published: September 09, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026